🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Feels like a tipping point towards bsky.app this last few days! See you there... bsky.app/profile/steven…

Speaking of S. aureus! SNAP Trial passed 3500! Writing papers: cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox Recruiting: Adj clinda vs not (all) Adj cefazolin vs not (MRSA) Oral switch vs IV (all) cefazolin +/- Erta/Placebo (MSSA) Dapto vs Vanco (MRSA, starts tomorrow!)

The SToP Trial has come to a close and we’re incredibly proud of all that was achieved. Hear from Professor Asha Bowen and Janella Isaac as they summarise almost a decade of work in a single video youtube.com/watch?v=p1mDyd…

Association of daily body temperature, white blood cell count, and C-reactive protein with mortality and persistent bacteremia in patients with Staphylococcus aureus bacteremia ✅ Just Accepted ✍️ Sean Ong, Steven Tong 🔗 bit.ly/3WOoxv7

Haven't posted about SNAP for a while: But we've just hit 4000 participants. Almost at 3 years since opening. And submitting two late breaker oral abstracts to ESCMID Global. Amazing progress and more to come. SNAP Trial Joshua Davis Todd C. Lee

This will be the best session on ECCMID. I'm sure, because it will be very important results, carefully delivered and then dissected. I'm 💯 sure it will change my practice.

Excited to announce that we randomised our first patient into the #ROADMAPtrial today! First of thousands, answering important questions in prosthetic joint infection. See roadmaptrial.com for more deets. #IDXposts #PJI

Excited to share our latest research published in The Lancet Microbe exploring epidemiology and lineage dynamics of invasive S. pyogenes across diverse regions of Australia. doi.org/10.1016/j.lanm…. A huge collaboration with many partners Steven Tong Mark_Davies_Lab Rebecca Chisholm. 🧵👇

Great work again from Ouli Xie! This time on epidemiology and lineage dynamics of invasive Streptococcus pyogenes in Australia - comparison between hyperendemic and usual urban regions. Published in The Lancet Microbe

It’s happening now! The results of the SNAP PSSA and MSSA domains Recently, the number of patients recruited in SNAP surpassed all randomized patients in staph aureus trials combined! #ESCMIDGlobal2025 Steven Tong Todd C. Lee

Amazing summary of the SNAP/CLOCEBA session from yestereday #ESCMIDGlobal. Thanks for posting Bryan White. Nailed all the key points!

Thanks Paul Sax for highlighting SNAP Trial ! Doherty Institute ESCMID UniMelb MDHS #IDTwitter Joshua Davis

Annual N95 fit-testing is still required based on 1 small study of 229 participants. In a study of 12,065 HCWs followed over 3 yrs, fit‑test failure was <0.5% (Martin et al). Annual fit‑testing still costs US healthcare ~$200–400 M/yr. Time to switch to every 3 years.

🆕💫 Systematic Review and Meta-Analysis Clinical Microbiology and Infection Connor Prosty Todd C. Lee Emily McDonald Steven Tong 30 observational studies( SNAP & CloCeBa not included) N: 3869 Cefazolin versus Antistaphylococcal Penicillins for the Treatment of MSSA Bacteremia #idxposts clinicalmicrobiologyandinfection.com/article/S1198-…

Amazing contribution Owen to the SNAP Trial community! The whole study only works because of your kind of engagement.

SNAP Trial is the little engine that could! Congratulations on passing 4500 participants Steven Tong Joshua Davis